BARRIER THERAPEUTICS INC 4
4 · BARRIER THERAPEUTICS INC · Filed Aug 6, 2008
Insider Transaction Report
Form 4
Bengal Acquisition Inc.
10% OwnerOther
Transactions
- Purchase
Common Stock
2008-08-06$4.15/sh+1,033,464$4,288,876→ 0 total
Footnotes (2)
- [F1]Charles W. Stiefel is the Chairman of the Board and Chief Executive Officer of Stiefel Laboratories, Inc. ("Stiefel"). Charles W. Stiefel, through his direct ownership of a majority of outstanding Class B shares of Stiefel (the Class B shares are entitled to elect a majority of the board of directors of Stiefel), and his ability pursuant to certain other arrangements to direct the voting of certain additional Class A and Class B shares of Stiefel, may be deemed to control Stiefel. As a result, Charles W. Stiefel may be deemed to share beneficial ownership of all shares of the Issuer's common stock beneficially owned by Stiefel. Since Bengal Acquisition Inc. ("Bengal") is a wholly-owned subsidiary of Stiefel, Stiefel may be deemed to share beneficial ownership of all shares of common stock of the Issuer beneficially owned by Bengal.
- [F2]On August 6, 2008, pursuant to the terms of an Agreement and Plan of Merger, dated as of June 23, 2008, by and between Stiefel, Bengal, and Barrier Therapeutics, Inc. (the "Issuer"), Bengal merged with and into the Issuer, with the Issuer surviving, and the shares of common stock, par value $0.0001 per share, of the Issuer were cancelled, and the holders thereof received $4.15 per share in exchange therefor.